Immunoglobulins: Global Market Outlook

Apr 2023| BIO241A| BCC Publishing
Sample Report

Report Highlights

The goal is to furnish an up-to-date analysis of the global immunoglobulins market and future opportunities in the market. The report provides an overview of the global immunoglobulins market and examines market trends. It also highlights major trends and challenges that affect the market and the vendor landscape. The scope of the study encompasses the current and forecast markets for normal and hyper immunoglobulins , includes market drivers and restraints, the competitive landscape, and current and emerging technologies. It also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.

Report Includes

  • A brief general outlook of the global market for immunoglobulins
  • Analyses of the global market trends, with historic market revenue data (sales figures) for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for the global immunoglobulins market in USD million terms, and corresponding market share analysis by product type, route of administration, and region
  • In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, current and future prospects in therapeutic treatments, and contributions to the overall market
  • Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration
  • Company profiles of the market leading players

Report Scope

The scope of this study encompasses the current and forecast markets for normal and hyper immunoglobulins. The report segments markets based on product type and route of administration. The report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market.

In terms of geographical regions, the report analyzes the market across North America, Europe, Asia-Pacific and the rest of the world (RoW). Key regions such as the U.S., Canada, Europe (U.K., Italy, France and Germany), Asia-Pacific (China, India and Japan) are highlighted in the discussion.

The report also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.

Frequently Asked Questions (FAQs)

The immunoglobulins market is projected to grow from $18.5 billion in 2021 to $26.3 billion in 2027, at a compound annual growth rate (CAGR) of 6.2% during the forecast period.
Increasing demand for immunoglobulins in various therapeutic treatments and increase in blood donations are some of the key factors driving the growth of the immunoglobulins market.
The immunoglobulins market is segmented on the type, route of administration, and region.
Normal Immunoglobulins segment will dominate the market by the end of 2027.
North America has the highest market share.
Grifols, Takeda, CSL, Kedrion, Octapharma, and LFB SA

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $18.5 billion
Market size forecast $26.3 billion
Growth rate CAGR of 6.2% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Type, route of administration, and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, Germany, France, Italy, U.K., Others, Japan, China, India, Australia, Others
Key Market Drivers
  • Increasing Demand for Immunoglobulins in Therapeutic Treatments
  • Increase in Blood Donations
  • Increasing Research on Alternative Therapies
  • High Manufacturing and Treatment Costs Associated with IG Products
  • Stringent Government Regulations and Low Reimbursement Policies
Companies studied
  • CSL LTD.
  • KEDRION S.p.A.
  • LFB S.A.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesMember Price
Full Report: Immunoglobulins: Global Market Outlook64Free
Immunoglobulins: Global Market Outlook

Single User License: $3500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.